GGrantIndex
← Leaderboards

Kirsten L Johansen

University Of California San Francisco

$9,035,881
Attributed
$14,667,284
Total exposure
12
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,667,284 · 11
AHRQ$0 · 1

By mechanism

R01$9,358,085 · 4
U01$2,647,931 · 1
K24$1,463,300 · 1
T32$803,504 · 1
R21$388,287 · 1
M01$6,177 · 3

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Quality Of Life

Research focus

Quality Of LifeHemodialysisDialysis ProcedureClinical ResearchEnd Stage Renal FailureNephrologyCaringPrevalenceExerciseKidney TransplantationHuman SubjectChronic Kidney FailureMuscle MetabolismLeadFrailtyPhysical FunctionFallsCohortHospitalizationCessation Of LifeModalityAttitudeEvaluationReporting

Grant awards (49)

Reaching Equity in ACess to Home Dialysis And Re-Transplantation (REACH-DART)$679,060
R01 · FY2025 · DK
Racial disparities in access to kidney transplantation$670,663
R01 · FY2025 · DK
Racial disparities in access to kidney transplantation$702,928
R01 · FY2024 · DK
Reaching Equity in ACess to Home Dialysis And Re-Transplantation (REACH-DART)$655,538
R01 · FY2024 · DK
Reaching Equity in ACess to Home Dialysis And Re-Transplantation (REACH-DART)$700,665
R01 · FY2023 · DK
Reaching Equity in ACess to Home Dialysis And Re-Transplantation (REACH-DART)$750,413
R01 · FY2022 · DK
Racial and ethnic disparities in access to kidney transplantation.$593,608
R01 · FY2021 · DK
Prevalence and Impact of Frailty among Dialysis Patients$149,045
K24 · FY2021 · DK · contact PI
Racial and ethnic disparities in access to kidney transplantation.$593,608
R01 · FY2020 · DK
Prevalence and Impact of Frailty among Dialysis Patients$148,786
K24 · FY2020 · DK · contact PI
The Hemodialysis Opioid Prescription Effort Consortium$2,647,931
U01 · FY2019 · DK · contact PI
Racial and ethnic disparities in access to kidney transplantation.$633,707
R01 · FY2019 · DK
Predictors and outcomes of frailty in dialysis patients$312,588
R01 · FY2019 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$148,584
K24 · FY2019 · DK · contact PI
Racial and ethnic disparities in access to kidney transplantation.$623,924
R01 · FY2018 · DK
Predictors and outcomes of frailty in dialysis patients$335,819
R01 · FY2018 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$147,802
K24 · FY2018 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$32,337
K24 · FY2018 · DK · contact PI
Predictors and outcomes of frailty in dialysis patients$566,499
R01 · FY2017 · DK · contact PI
Academic Training Program in Nephrology$348,672
T32 · FY2017 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$181,142
K24 · FY2017 · DK · contact PI
Academic Training Program in Nephrology$71,904
T32 · FY2017 · DK · contact PI
Predictors and outcomes of frailty in dialysis patients$632,296
R01 · FY2016 · DK · contact PI
Academic Training Program in Nephrology$382,928
T32 · FY2016 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$131,226
K24 · FY2014 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$131,231
K24 · FY2013 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$131,233
K24 · FY2012 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$132,106
K24 · FY2011 · DK · contact PI
Prevalence and Impact of Frailty among Dialysis Patients$129,808
K24 · FY2010 · DK · contact PI
Effects of N-acetylcystein on Muscle Fatigue in ESRD$191,287
R21 · FY2007 · DK · contact PI
Effects of N-acetylcystein on Muscle Fatigue in ESRD$197,000
R21 · FY2006 · DK · contact PI
ANABOLIC STEROIDS AND EXERCISE IN HEMODIALYSIS$2,284
M01 · FY2005 · RR
Anabolic steroids and exercise in hemodialysis$3,329
M01 · FY2004 · RR
ANABOLIC STEROIDS AND EXERCISE IN HEMODIALYSIS$320,006
R01 · FY2002 · DK
NUTRITIONAL/FUNCTIONAL ASSESSMENT OF DIALYSIS PATIENTS$0
M01 · FY2002 · RR
NUTRITIONAL/FUNCTIONAL ASSESSMENT OF DIALYSIS PATIENTS$0
M01 · FY2002 · RR
EFFECTS OF ACIDOSIS ON EXERCISE INDUCED MUSCLE PROTEIN SYNTHESIS$0
M01 · FY2002 · RR
EFFECTS OF ACIDOSIS ON EXERCISE INDUCED MUSCLE PROTEIN SYNTHESIS$0
M01 · FY2002 · RR
ANABOLIC STEROIDS AND EXERCISE IN HEMODIALYSIS$297,698
R01 · FY2001 · DK
NUTRITIONAL/FUNCTIONAL ASSESSMENT OF DIALYSIS PATIENTS$0
M01 · FY2001 · RR
Factors Affecting Choice of Types of Hemodialysis Access$0
R03 · FY2001 · HS
EFFECTS OF ACIDOSIS ON EXERCISE INDUCED MUSCLE PROTEIN SYNTHESIS$0
M01 · FY2001 · RR
ANABOLIC STEROIDS AND EXERCISE IN HEMODIALYSIS$289,065
R01 · FY2000 · DK
EFFECTS OF ACIDOSIS ON EXERCISE INDUCED MUSCLE PROTEIN SYNTHESIS$564
M01 · FY2000 · RR
EFFECTS OF ACIDOSIS ON EXERCISE INDUCED MUSCLE PROTEIN SYNTHESIS$0
M01 · FY2000 · RR
NUTRITIONAL/FUNCTIONAL ASSESSMENT OF DIALYSIS PATIENTS$0
M01 · FY2000 · RR
NUTRITIONAL/FUNCTIONAL ASSESSMENT OF DIALYSIS PATIENTS$0
M01 · FY2000 · RR
NUTRITIONAL/FUNCTIONAL ASSESSMENT OF DIALYSIS PATIENTS$0
M01 · FY2000 · RR
EFFECTS OF ACIDOSIS ON EXERCISE INDUCED MUSCLE PROTEIN SYNTHESIS$0
M01 · FY2000 · RR